Literature DB >> 8626898

CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors.

S H Kim1, W H Kim, K J Park, J K Lee, J S Kim.   

Abstract

PURPOSE: The purposes of this study were to evaluate the CT and MR findings of Krukenberg tumors and to compare them with those of primary ovarian tumors.
METHOD: This study included 20 patients with Krukenberg tumors and 65 patients with various primary ovarian tumors. CT/MR/both imaging studies were available in 15/1/4 patients with Krukenberg tumor and 31/10/24 patients with primary ovarian tumors, respectively. Imaging findings of the tumors were categorized into three subgroups: a solid mass with intratumoral cysts, a solid mass without intratumoral cysts, and a predominantly cystic mass.
RESULTS: Among 32 Krukenberg tumors (bilateral in 12 patients), 22 were solid masses with intratumoral cysts, in 14 of which the wall of the intratumoral cysts showed apparently strong contrast enhancement on CT and/or MRI. Six Krukenberg tumors were solid masses without intratumoral cysts, and four were predominantly cystic masses. Imaging findings of 88 primary ovarian tumors (bilateral in 23 patients) were 5 solid masses with intratumoral cysts, 27 solid masses without intratumoral cysts, and 56 predominantly cystic masses. None of the five primary ovarian tumors with solid mass with intratumoral cysts demonstrated apparently strong contrast enhancement of the cyst wall.
CONCLUSION: Krukenberg tumor should be suspected when one sees solid ovarian tumors containing well demarcated intratumoral cystic lesions, especially if the walls of those cysts demonstrate apparently strong contrast enhancement.

Entities:  

Mesh:

Year:  1996        PMID: 8626898     DOI: 10.1097/00004728-199605000-00013

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  20 in total

1.  Recurrent small bowel obstruction in an elderly woman.

Authors:  T S Chandrasekar; M Murugesh; M Murthy; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2010-03

2.  MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology.

Authors:  Marc Bazot; Jinane Nassar-Slaba; Isabelle Thomassin-Naggara; Annie Cortez; Serge Uzan; Emile Daraï
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

3.  F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.

Authors:  Hye Lim Park; Ie Ryung Yoo; Joo Hyun O; Eun Ji Han; Sung Hoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-03       Impact factor: 4.553

4.  Jejunal cancer detected after a resection of bilateral ovarian metastasis: report of a case.

Authors:  Hiroshi Maekawa; Koichi Sato; Yoshihiro Komatsu; Hajime Orita; Mutsumi Sakurada
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

5.  A curious discourse of Krukenberg tumor: a case report.

Authors:  Somak Das; Diwakar Sahu; Majid Wani; Prasanna Kumar Reddy
Journal:  J Gastrointest Oncol       Date:  2014-12

6.  MR imaging findings of ovarian cystadenofibroma and cystadenocarcinofibroma: clues for the differential diagnosis.

Authors:  Dae Chul Jung; Sun Ho Kim; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

Review 7.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  Dyspnoea and the ovaries: a rare presentation of Krukenberg tumour.

Authors:  Wasiq Faraz Rawasia; Udit Chaddha; Karim El-Kersh; Rafael L Perez
Journal:  BMJ Case Rep       Date:  2013-02-01

Review 9.  Ovarian cancer: the clinical role of US, CT, and MRI.

Authors:  Kaori Togashi
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

10.  Bilateral Ovarian Tumors on MRI: How Should We Differentiate the Lesions?

Authors:  Naoko Mukuda; Shinya Fujii; Chie Inoue; Takeru Fukunaga; Tetsuro Oishi; Tasuku Harada; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.